V
VistaGen Therapeutics D
D
VTGN
0.63840
USD
0.02
(2.59%)
مفتوح الان
حجم التداول
3,158
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
26,195,118
المقالات
العنوان: VistaGen Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mentalfatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.